首页> 美国卫生研究院文献>Biomicrofluidics >Isolation of viable cancer cells in antibody-functionalized microfluidic devices
【2h】

Isolation of viable cancer cells in antibody-functionalized microfluidic devices

机译:抗体功能化微流控设备中活癌细胞的分离

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Microfluidic devices functionalized with EpCAM antibodies were utilized for the capture of target cancer cells representing circulating tumor cells (CTCs). The fraction of cancer cells captured from homogeneous suspensions is mainly a function of flow shear rate, and can be described by an exponential function. A characteristic shear rate emerges as the most dominant parameter affecting the cell attachment ratio. Utilizing this characteristic shear rate as a scaling factor, all attachment ratio results for various combinations of receptor and ligand densities collapsed onto a single curve described by the empirical formula. The characteristic shear rate increases with both cell-receptor and surface-ligand densities, and empirical formulae featuring a product of two independent cumulative distributions described well these relationships. The minimum detection limit in isolation of target cancer cells from binary mixtures was experimentally explored utilizing microchannel arrays that allow high-throughput processing of suspensions about 0.5 ml in volume, which are clinically relevant, within a short time. Under a two-step attachment/detachment flow rate, both high sensitivity (almost 1.0) and high specificity (about 0.985) can be achieved in isolating target cancer cells from binary mixtures even for the lowest targeton-target cell concentration ratio of 1:100 000; this is a realistic ratio between CTCs and white blood cells in blood of cancer patients. Detection of CTCs from blood samples was also demonstrated using whole blood from healthy donors spiked with cancer cells. Finally, the viability of target cancer cells released after capture was confirmed by observing continuous cell growth in culture.
机译:利用EpCAM抗体功能化的微流控设备可用于捕获代表循环肿瘤细胞(CTC)的靶癌细胞。从均相悬浮液中捕获的癌细胞分数主要是流量剪切速率的函数,并且可以用指数函数来描述。特征剪切速率是影响细胞附着率的最主要参数。利用该特征剪切速率作为比例因子,受体和配体密度的各种组合的所有附着率结果均折叠到经验公式所描述的一条曲线上。特征剪切速率随细胞受体和表面配体密度的增加而增加,具有两个独立累积分布乘积的经验公式很好地描述了这些关系。利用微通道阵列实验性探索了从二元混合物中分离靶癌细胞的最低检测限,该微通道阵列可在短时间内高通量处理约0.5 µml体积的临床相关悬浮液。在两步附着/分离流速下,即使最低的靶/非靶细胞浓度比为1,也可以从二元混合物中分离靶癌细胞,同时获得高灵敏度(接近1.0)和高特异性(约0.985) :100 000;这是癌症患者血液中CTC与白细胞之间的实际比率。还证明了使用来自健康供体的全血和掺有癌细胞的血液样品中的四氯化碳检测。最后,通过观察培养物中细胞的连续生长来确认捕获后释放的靶癌细胞的活力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号